Clinical Trial Update: Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

View source ↗

Summary

This update reports retrospective real-world data on the effectiveness and safety of liraglutide and DPP-4 inhibitors in European primary care for Type 2 Diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• Onglyza (Saxagliptin)
• Tradjenta (Linagliptin)
• Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED